Bridge to Life Ltd., a leader in organ preservation solutions and perfusion technology, today announced the appointment of David Castiglioni as Chief Commercial Officer (CCO). In this role, Mr.
News Medical on MSN
FUJIFILM Biosciences Introduces BalanCD HEK293 Perfusion A Medium to Enable Gene Therapy Production
BalanCD HEK293 Perfusion A uses suspension HEK293 cells and perfusion technology to provide reliable, efficient, and scalable production of viral vectors for development of gene therapies. HEK293 ...
WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the completion of the world’s first donor kidney ...
The medium, which is designed for high density perfusion culture, is available in a variety of media package options for continuous processing.
New Modes Are Beginning to Gain Ground on Fed-batch Strategy The therapeutic success of highly efficacious complex biologicals that are almost exclusively produced in cell culture such as antibodies ...
ANDOVER, Mass., Aug. 2, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...
The perfusion of a burn injury can now rapidly be determined by using a new technique. Using the perfusion image made by a laser and an ultra fast camera, doctors will be able to determine whether a ...
The article Hofstra Adds Cutting Edge Virtual Reality To Cardiovascular Program appeared first on Garden City Patch.
When doing open-heart surgery, the surgeon needs a still heart and lungs to work. The patient still needs oxygen circulated through the bloodstream to survive. Thus, cardiovascular perfusionists (also ...
FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results